Research Directory

Checkpoint inhibitors - A new horizon for cancer therapy

Read more

Will scanners be the key to translational medicine?

Read more

Why the time has come for MidPharmas

Read more

Alkermes pioneers trial design in depression

Read more

The EU Clinical Trials Regulation: Legislators see light at the end of the tunnel

Read more

Oncology Development Review - 2013: Competition for new cancer treatments intensifies

Read more

Commentary: The outlook for biotech seems rosy - for now

Read more

Outlook brightens for regenerative medicine

Read more

Targeting new medicines at Roche

Read more

MorphoSys Innovation Capital: A venture fund with appetite for platforms

Read more